(ABEV) Ambev - Overview
Sector: Consumer Defensive | Industry: Beverages - Brewers | Exchange: NYSE (USA) | Market Cap: 50.923m USD | Total Return: 35.4% in 12m
Avg Turnover: 90.3M
EPS Trend: -82.2%
Qual. Beats: 1
Rev. Trend: 76.3%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
Idiosyncratic Leader
Ambev S.A. is a major beverage manufacturer and distributor operating across Latin America, Canada, and the Caribbean. A subsidiary of Interbrew International B.V. (Anheuser-Busch InBev), the company manages a diverse portfolio including beer, soft drinks, and ready-to-drink cocktails under brands such as Brahma, Skol, and Guaraná Antarctica.
The company utilizes an extensive distribution network to supply products directly to supermarkets, retailers, and third-party distributors. As a participant in the global brewing sector, Ambev benefits from significant economies of scale in raw material procurement and logistics, which are critical drivers of profitability in the high-volume beverage industry.
For a more detailed breakdown of the companys financial health, investors can explore the fundamental analysis tools on ValueRay.
- Fluctuations in the Brazilian Real impact raw material costs and dividend yields
- Premium brand expansion drives margin growth across Latin American and Canadian markets
- Input cost volatility for aluminum and agricultural commodities affects operating margins
- Consumer purchasing power in Brazil dictates core beer segment volume and revenue
- Regulatory changes to tax subsidies in Brazil threaten net income and cash flow
| Net Income: 15.6b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 0.57 > 1.0 |
| NWC/Revenue: 1.33% < 20% (prev 4.59%; Δ -3.26% < -1%) |
| CFO/TA 0.18 > 3% & CFO 26.4b > Net Income 15.6b |
| Net Debt (-13.8b) to EBITDA (29.0b): -0.48 < 3 |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.7b) vs 12m ago -0.39% < -2% |
| Gross Margin: 51.48% > 18% (prev 51.46%; Δ 0.02% > 0.5%) |
| Asset Turnover: 60.82% > 50% (prev 62.24%; Δ -1.41% > 0%) |
| Interest Coverage Ratio: 8.09 > 6 (EBIT TTM 22.2b / Interest Expense TTM 2.75b) |
| A: 0.01 (Total Current Assets 42.8b - Total Current Liabilities 41.7b) / Total Assets 143b |
| B: 0.03 (Retained Earnings 4.31b / Total Assets 143b) |
| C: 0.15 (EBIT TTM 22.2b / Avg Total Assets 145b) |
| D: 1.74 (Book Value of Equity 90.1b / Total Liabilities 51.9b) |
| Altman-Z'' = 3.01 = A |
| DSRI: 1.03 (Receivables 8.83b/8.90b, Revenue 88.2b/91.7b) |
| GMI: 1.00 (GM 51.46% / 51.48%) |
| AQI: 1.01 (AQ_t 0.52 / AQ_t-1 0.51) |
| SGI: 0.96 (Revenue 88.2b / 91.7b) |
| TATA: -0.08 (NI 15.6b - CFO 26.4b) / TA 143b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of June 08, 2026, the stock is trading at USD 3.12 with a total of 20,496,859 shares traded.
Over the past week, the price has changed by -2.80%,
over one month by -7.42%,
over three months by +6.85% and
over the past year by +35.37%.
Ambev has received a consensus analysts rating of 3.42. Therefore, it is recommended to hold ABEV.
- StrongBuy: 2
- Buy: 2
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 3.3 | 6.7% |
Market Cap BRL = 258b (50.9b USD * 5.0645 USD.BRL)
P/E Trailing = 16.35
P/E Forward = 15.625
P/S = 0.5773
P/B = 2.8327
P/EG = 2.2562
Revenue TTM = 88.2b BRL
EBIT TTM = 22.2b BRL
EBITDA TTM = 29.0b BRL
Long Term Debt = 234.2m BRL (from longTermDebt, last quarter)
Short Term Debt = 1.10b BRL (from shortTermDebt, last quarter)
Debt = 5.83b BRL (from shortLongTermDebtTotal, last quarter) + Leases 2.73b
Net Debt = -13.8b BRL (calculated: Debt 5.83b - CCE 19.6b)
Enterprise Value = 244b BRL (258b + Debt 5.83b - CCE 19.6b)
Interest Coverage Ratio = 8.09 (Ebit TTM 22.2b / Interest Expense TTM 2.75b)
EV/FCF = 11.02x (Enterprise Value 244b / FCF TTM 22.2b)
FCF Yield = 9.08% (FCF TTM 22.2b / Enterprise Value 244b)
FCF Margin = 25.11% (FCF TTM 22.2b / Revenue TTM 88.2b)
Net Margin = 17.66% (Net Income TTM 15.6b / Revenue TTM 88.2b)
Gross Margin = 51.48% ((Revenue TTM 88.2b - Cost of Revenue TTM 42.8b) / Revenue TTM)
Gross Margin QoQ = 51.56% (prev 52.63%)
Tobins Q-Ratio = 1.71 (Enterprise Value 244b / Total Assets 143b)
Interest Expense / Debt = 47.15% (Interest Expense 2.75b / Debt 5.83b)
Taxrate = 17.58% (3.43b / 19.5b)
NOPAT = 18.3b (EBIT 22.2b * (1 - 17.58%))
Current Ratio = 1.03 (Total Current Assets 42.8b / Total Current Liabilities 41.7b)
Debt / Equity = 0.06 (Debt 5.83b / totalStockholderEquity, last quarter 90.1b)
Debt / EBITDA = -0.48 (Net Debt -13.8b / EBITDA 29.0b)
Debt / FCF = -0.62 (Net Debt -13.8b / FCF TTM 22.2b)
Total Stockholder Equity = 90.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.74% (Net Income 15.6b / Total Assets 143b)
RoE = 17.19% (Net Income TTM 15.6b / Total Stockholder Equity 90.6b)
RoCE = 24.48% (EBIT 22.2b / Capital Employed (Equity 90.6b + L.T.Debt 234.2m))
RoIC = 18.75% (NOPAT 18.3b / Invested Capital 97.8b)
WACC = 7.53% (E(258b)/V(264b) * Re(6.82%) + D(5.83b)/V(264b) * Rd(47.15%) * (1-Tc(0.18)))
Discount Rate = 6.82% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -76.41 | Cagr: -0.43%
[DCF] Terminal Value 75.52% ; FCFF base≈22.1b ; Y1≈22.3b ; Y5≈23.9b
[DCF] Fair Price = 24.69 (EV 371b - Net Debt -13.8b = Equity 384b / Shares 15.6b; r=8.35% [WACC [floored]]; 5y FCF grow 0.59% → 2.50% )
EPS Correlation: -82.22 | EPS CAGR: -6.13% | SUE: 2.02 | # QB: 1
Revenue Correlation: 76.34 | Revenue CAGR: 4.85% | SUE: 0.03 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.04 | Chg30d=N/A | Revisions=+20% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.05 | Chg30d=+2.36% | Revisions=+20% | Analysts=3
EPS current Year (2026-12-31): EPS=0.20 | Chg30d=+3.80% | Revisions=+56% | GrowthEPS=+11.3% | GrowthRev=+4.3%
EPS next Year (2027-12-31): EPS=0.22 | Chg30d=+3.16% | Revisions=+33% | GrowthEPS=+11.4% | GrowthRev=+4.6%
[Analyst] Revisions Ratio: +56%